Search

Author/Creator Armstrong, Andrew J.

1. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer. Issue 16 (5th May 2021)

Authors:
George, Daniel J.; Halabi, Susan; Heath, Elisabeth I.; Sartor, A. Oliver; Sonpavde, Guru P.; Das, Devika; Bitting, Rhonda L.; Berry, William; Healy, Patrick; Anand, Monika; Winters, Carol; Riggan, Colleen; Kephart, Julie; Wilder, Rhonda; Shobe, Kellie; Rasmussen, Julia; Milowsky, Matthew I.; Flem...
Journal:
Cancer
Issue:
Volume 127:Issue 16(2021)
Page Start:
2954
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer. Issue 9 (8th January 2019)

Authors:
Sonpavde, Guru; Agarwal, Neeraj; Pond, Gregory Russell; Nagy, Rebecca J.; Nussenzveig, Roberto H.; Hahn, Andrew W.; Sartor, Oliver; Gourdin, Theodore Stewart; Nandagopal, Lakshminarayanan; Ledet, Elisa M.; Naik, Gurudatta; Armstrong, Andrew J.; Wang, Jue; Bilen, Mehmet Asim; Gupta, Shilpa; Grivas...
Journal:
Cancer
Issue:
Volume 125:Issue 9(2019)
Page Start:
1459
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical outcomes and survival surrogacy studies of prostate‐specific antigen declines following enzalutamide in men with metastatic castration‐resistant prostate cancer previously treated with docetaxel. Issue 12 (7th February 2017)

Authors:
Armstrong, Andrew J.; Saad, Fred; Phung, De; Dmuchowski, Carl; Shore, Neal D.; Fizazi, Karim; Hirmand, Mohammad; Forer, David; Scher, Howard I.; Bono, Johann De
Journal:
Cancer
Issue:
Volume 123:Issue 12(2017)
Page Start:
2303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. (1st March 2021)

Authors:
Laccetti, Andrew L.; Garmezy, Benjamin; Xiao, Lianchun; Economides, Minas; Venkatesan, Aradhana; Gao, Jianjun; Jonasch, Eric; Corn, Paul; Zurita‐Saavedra, Amado; Brown, Landon C.; Kao, Chester; Kinsey, Emily N.; Gupta, Rajan T.; Harrison, Michael R.; Armstrong, Andrew J.; George, Daniel J.; Tanni...
Journal:
Cancer medicine
Issue:
Volume 10:Number 7(2021)
Page Start:
2341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer. Issue 4 (28th November 2019)

Authors:
Gupta, Santosh; Hovelson, Daniel H.; Kemeny, Gabor; Halabi, Susan; Foo, Wen‐Chi; Anand, Monika; Somarelli, Jason A.; Tomlins, Scott A.; Antonarakis, Emmanuel S.; Luo, Jun; Dittamore, Ryan V.; George, Daniel J.; Rothwell, Colin; Nanus, David M.; Armstrong, Andrew J.; Gregory, Simon G.
Journal:
Genes, chromosomes & cancer
Issue:
Volume 59:Issue 4(2020)
Page Start:
225
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302. (July 2022)

Authors:
Wilson, Brooke E.; Armstrong, Andrew J.; de Bono, Johann; Sternberg, Cora N.; Ryan, Charles J.; Scher, Howard I.; Smith, Matthew R.; Rathkopf, Dana; Logothetis, Christopher J.; Chi, Kim N.; Jones, Robert J.; Saad, Fred; De Porre, Peter; Tran, NamPhuong; Hu, Peter; Gillessen, Silke; Carles, Joan; ...
Journal:
European journal of cancer
Issue:
Volume 170(2022)
Page Start:
296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗